Results 151 to 160 of about 15,175 (215)

Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026. [PDF]

Ther Adv Hematol
Al-Zubaidi N, Makris K, Sriskandarajah P.   +2 more
europepmc   +1 more source

Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97). [PDF]

Front Oncol
Felser S, Koeppel M, Kuehl R, le Coutre P, Al-Ali HK, Schulze S, Muegge LO, Bormann J, Geissler J, Dadgar A, Junghanss C, Ulbricht S.   +11 more
europepmc   +1 more source

Balancing Bleeding and Clot: Type 2 Heparin-Induced Thrombocytopenia With Extensive Thromboses in a Patient With Subdural Hematoma. [PDF]

Cureus
Annan GK, Enninful E, Egwuonwu C, Atencah SE, Berchie PO.   +4 more
europepmc   +1 more source

Driver mutation-defined molecular landscapes of essential thrombocythemia. [PDF]

Blood Sci
Lorenzen AL, Huang G.
europepmc   +1 more source

Essential thrombocythemia

International Journal of Biomedical and Advance Research, 2013
Adnan Bashir Bhatti, Farhan Ali, Siddique Akbar Satti   +2 more
openaire   +2 more sources

Immature Platelet Fraction as a Potential Biomarker of Dysregulated Thrombopoiesis in Philadelphia-Negative Myeloproliferative Neoplasms. [PDF]

J Clin Med
Zekanovic I, Marketin T, Moric Peric M, Zekanovic D, Vulic A, Milos M, Bogic A, Marcinkovic M, Grbic Pavlovic P, Radic Antolic M, Knezevic J, Jurlina L, Boban A.   +12 more
europepmc   +1 more source

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET). [PDF]

Lancet Reg Health Am
Reeves BN, El Chaer F, Foltz L, Tashi T, Abu-Zeinah G, Qin A, Lucas J, Halpern AB, Maze D, Safah H, O'Connell CL, Goel S, Rein L, Fang B, How J, Babu S, Li Z, Cerquozzi S, Oh ST, Hunter AM, Podoltsev N, Vachhani P, Cunningham JM, Hillis C, Bose P, Yacoub A, Mascarenhas J, Zagrijtschuk O, Castro H, Mesa RA, Masarova L.   +30 more
europepmc   +1 more source

Analytical cohort study on splenomegaly and cytopenias in myeloproliferative disorders. [PDF]

Bioinformation
Sinha S, Rajan VP, Nair AU, Jakka AP, Chandrasekaran SP.   +4 more
europepmc   +1 more source

Massive Anterior STEMI Due to Essential Thrombocythemia Leading to Urgent Thrombocytapheresis. [PDF]

JACC Case Rep
Rioux AV, Morin L, Bernier M, Avram AT, Poulin A.   +4 more
europepmc   +1 more source

Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera. [PDF]

Blood Cancer J
Angona A, Cuevas B, Pérez-Encinas M, Ferrer-Marin F, Senín A, Arellano-Rodrigo E, Hernández-Boluda JC, Mata Vázquez MI, Caballero-Navarro G, Gómez-Casares MT, Magro E, Carreño-Tarragona G, Cortés-Vázquez MA, Pérez López R, García-Gutiérrez V, Noya-Pereira MS, Alonso-Dominguez JM, Sierra-Aisa C, Fox L, García Hernández C, Guerra JM, Cerezo E, Gasior M, Santaliestra M, Díez I, Cuevas MV, Sanz L, Pastor I, Stuckey R, Vélez P, Auría-Caballero C, Alvarez-Larrán A.   +31 more
europepmc   +1 more source